Bettman, J. R., Payne, J. W., & Staelin, R. (1986). Cognitive considerations in designing effective labels for presenting risk information. Journal of Public Policy and Marketing,
Busch, S. H., Frank, R. G., Martin, A., & Barry, C. (2010). Characterizing declines in pediatric antidepressant use after new risk disclosures. Medical Care Research and Review (advance online publication, July 30, 2010).
Cawley, J., & Rizzo, J. A. (2008). Spillover effects of prescription drug withdrawals. Advances in Health Economics and Health Services Research,
Donald, S., & Lang, K. (2007). Inference with differences-in-differences and other panel data. Review of Economics and Statistics,
Fischer, M., Servi, A., Polinski, J., & Wang, P. (2007). Restrictions on antidepressant medications for children: a review of medicaid policy. Psychiatric Services,
Food and Drug Administration. (2003). FDA public health advisory. Food and Drug Administration. http://www.fda.gov/CDER/drug/advisory/mdd.htm.
Food and Drug Administration. (2004). FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. Press release October 15, 2004. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108363.htm.
Grijalva, C. G., Nuorti, J. P., & Griffin, M. R. (2009). Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. Journal of the American Medical Association,
Grossman, M. (1972). On the concept of health capital and the demand for health. Journal of Political Economy,
Guo, J. J., Curkendall, S., Jones, J. K., Fife, D., Goehring, E., & She, D. (2003). Impact of cisapride label changes on codispensing of contraindicated medications. Pharmacoepidemiology and Drug Safety,
Harris, E. C., & Barraclough, B. (1998). Excess mortality of mental disorder. The British Journal of Psychiatry,
Hirschfeld, R. M., Keller, M. B., Panico, S., Arons, B. S., Barlow, D., Davidoff, F., et al. (1997). The national depressive and manic-depressive association consensus statement on the undertreatment of depression. Journal of the American Medical Association,
Jick, H., Kaye, J. A., & Jick, S. S. (2004). Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association,
Linsenmayer, M., Scheffrahn, M., McLain, M. E., & Brenner, D. (1999). Frequency and demographics of depression: A study of the UT-Austin GSLIS student population. Austin, TX: University of Texas-Austin.
Lleras-Muney, A., & Lichtenberg, F. R. (2003). The effect of education on medical technology adoption: Are the more educated more likely to use new drugs? National Bureau of Economic Research. http://www.nber.org/CRIW/papers/lleras.pdf.
Ludwig, J., & Marcotte, D. E. (2005). Anti-depressants, suicide, and drug regulation. Journal of Policy Analysis and Management,
Magat, W. A., Viscusi, W. K., & Huber, J. (1988). Consumer processing of hazard warning information. Journal of Risk and Uncertainty,
Mallick, R., Jieling, C., Entshuah, R., & Schatzberg, A. (2003). Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression. Journal of Clinical Psychiatry,
McKeown, R., Cuffe, S., & Schulz, R. (2006). US suicide rates by age group, 1970–2002: An examination of recent trends. American Journal of Public Health, 96, 1744–1751.
Olfson, M., Marcus, S. C., & Druss, B. (2008). Effects of food and drug administration warnings on antidepressant use in a national sample. Archives of General Psychiatry,
Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. A. (2002). National trends in the outpatient treatment of depression. Journal of the American Medical Association,
Olfson, M., Marcus, S. C., & Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Archives of General Psychiatry,
Pakenham, K. I., & Cox, S. (2008). Development of benefit finding in multiple sclerosis (MS) caregiving scale: a longitudinal study of relations between benefit finding and adjustment. British Journal of Health Psychology,
Parkinson, K., Price, J., Simon, K. I., & Tennyson, S. (2008). The influence of FDA advisory information and black box warnings on consumer use of prescription antidepressants (October 29, 2008). SSRN working paper #1292082.
Price, J., & Simon, K. I. (2009). Does the impact of medical research on medical practice differ by patient education? Journal of Health Economics,
Rappaport, N., Prince, J. B., & Bostic, J. Q. (2005). Lost in the black box: Juvenile depression, suicide, and the FDA’s black box. Journal of Pediatrics,
Ringold, S. (2005). Antidepressant warning focuses attention on unmet need for child psychiatrists. Journal of the American Medical Association,
Sharp, I. R., & Chapman, J. E. (2004). Antidepressants and increased suicidality: The media portrayal of controversy. The Scientifc Review of Mental Health Practice, 3.
Simon, K. I., Tennyson, S., & Hudman, J. (2009). Do state cost control policies reduce medicaid prescription drug spending? Risk Management and Insurance Review,
Smith, D. H., et al. (2006). The impact of prescribing safety alerts for elderly persons in an electronic medical record: An interrupted time series evaluation. Archives of Internal Medicine,
Soumerai, S. B. (2004). Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs,
Soumerai, S. B., Avorn, J., Gortmaker, S., & Hawley, S. (1987). Effect of government and commercial warnings on reducing prescription misuse: The case of propoxyphene. The American Journal of Public Health,
Stewart, D. W., & Martin, I. M. (1994). Intended and unintended consequences of warning messages: A review and synthesis of empirical research. Journal of Public Policy & Marketing,
Thomas, C. P., Conrad, P., Casler, R., & Goodman, E. (2006). Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatric Services,
Vernacchio, L., Kelly, J. P., Kaufman, D. W., & Mitchell, A. A. (2008). Cough and cold medication use by US children, 1999–2006: Results for the Slone survey. Pediatrics,
122(2), e323–e329. doi:10.1542/peds.2008-0498.
Viscusi, W. K. (1990). Do smokers underestimate risk? Journal of Political Economy,
Wagner, A. K., et al. (2006). FDA drug prescribing warnings: Is the black box half empty or half full? Pharmacoepidemiology and Drug Safety,
Weatherby, L. B., Norstrom, B. L., Fife, D., & Walker, A. M. (2002). The impact of wording in ‘Dear Doctor’ letters and in black box labels. Clinical Pharmacology and Therapeutics,
Wong, I. C. K., Besag Frank, M. C., Santosh, P. J., & Murray, M. L. (2004). Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Safety,